{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T10:51:46Z","timestamp":1779101506921,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":22,"publisher":"Springer US","isbn-type":[{"value":"9780306461354","type":"print"},{"value":"9780585379708","type":"electronic"}],"license":[{"start":{"date-parts":[[1999,1,1]],"date-time":"1999-01-01T00:00:00Z","timestamp":915148800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1999,1,1]],"date-time":"1999-01-01T00:00:00Z","timestamp":915148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999]]},"DOI":"10.1007\/978-0-585-37970-8_5","type":"book-chapter","created":{"date-parts":[[2008,8,14]],"date-time":"2008-08-14T20:25:35Z","timestamp":1218745535000},"page":"75-81","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Mood and Cognitive Disorders in Cancer Patients Receiving Cytokine Therapy"],"prefix":"10.1007","author":[{"given":"Christina A.","family":"Meyers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,11,23]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1093\/oxfordjournals.annonc.a059358","volume":"6","author":"R. Amato","year":"1995","unstructured":"Amato, R., Meyers, C., Ellerhorst, J., Finn, L., Kilbourn, R., Sella, A., & Logothetis, C. (1995). A phase I trial of intermittent high-dose \u03b1-interferon and dexamethasone in metastatic renal cell carcinoma. Annals of Oncology, 6, 911\u2013914.","journal-title":"Annals of Oncology"},{"key":"5_CR2","volume-title":"Subcortical Dementia","author":"J. L. Cummings","year":"1990","unstructured":"Cummings, J. L. (1990). Subcortical Dementia. New York: Oxford University Press."},{"issue":"Supplement 1","key":"5_CR3","first-page":"48","volume":"25","author":"M. C. Dalakas","year":"1998","unstructured":"Dalakas, M. C., Mock, V., & Hawkins, M. J. (1998). Fatigue: definitions, mechanisms, and paradigms for study. Seminars in Oncology, 25Supplement 1, 48\u201353.","journal-title":"Seminars in Oncology"},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0033-3182(94)71769-2","volume":"35","author":"L. S. Goldman","year":"1994","unstructured":"Goldman, L. S. (1994). Successful treatment of interferon alfa-induced mood disorder with nortriptyline (Letter to the editor). Psychosomatics, 35, 412\u2013413.","journal-title":"Psychosomatics"},{"key":"5_CR5","doi-asserted-by":"crossref","unstructured":"Ho, B. T., Lu, J. G., Huo, Y. Y., Fan, S. H., Meyers, C. A., Tansey, L. W., Payne, R., & Levin, V. A. The opioid mechanism of interferon-\u03b1 action. Anti-Cancer Drugs, 5, 90\u201394.","DOI":"10.1097\/00001813-199402000-00014"},{"issue":"Supplement 1","key":"5_CR6","first-page":"54","volume":"25","author":"T. H. J. Jones","year":"1998","unstructured":"Jones, T. H. J., Wadler, S., & Hupart, K. H. (1998). Endocrine-mediate mechanisms of fatigue during treatment with interferon-\u03b1. Seminars in Oncology, 25Supplement 1, 54\u201363.","journal-title":"Seminars in Oncology"},{"key":"5_CR7","first-page":"760","volume":"88","author":"J. L. Levenson","year":"1993","unstructured":"Levenson, J. L. & Fallon, H. J. (1993). Fluoxetine treatment of depression caused by interferon-alpha. American Journal of Gastroenterology, 88, 760\u2013761.","journal-title":"American Journal of Gastroenterology"},{"issue":"Supplement1","key":"5_CR8","first-page":"30","volume":"25","author":"I. Licinio","year":"1998","unstructured":"Licinio, I, Kling, M. A., & Hauser, P. (1998). Cytokines and brain function: relevance to interferon-\u03b1-induced mood and cognitive changes. Seminars in Oncology, 25Supplement1, 30\u201338.","journal-title":"Seminars in Oncology"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1176\/jnp.8.1.74","volume":"8","author":"R. L. Mapou","year":"1996","unstructured":"Mapou, R. L., Law, W. A., Wagner, K., Malone, J. L., & Skillman, D. R. (1996). Neuropsychological effects of interferon alfa-n3 treatment in asymptomatic human immunodeficiency virus-1-infected individuals. Journal of Neuropsychiatry and Clinical Neurosciences, 8, 74\u201381.","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1212\/WNL.42.2.434","volume":"42","author":"C. A. Meyers","year":"1992","unstructured":"Meyers, C. A. & Abbruzzese, J. L. (1992). Cognitive functioning in cancer patients: effect of previous treatment. Neurology, 42, 434\u2013436.","journal-title":"Neurology"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2165\/00023210-199503010-00006","volume":"3","author":"C. A. Meyers","year":"1995","unstructured":"Meyers, C. A. & Valentine, A. D. (1995). Neurologic and psychiatric adverse effects of immunological therapy. CNS Drugs, 3, 56\u201368.","journal-title":"CNS Drugs"},{"key":"5_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1176\/jnp.6.3.285","volume":"6","author":"C. A. Meyers","year":"1994","unstructured":"Meyers, C. A., Valentine, A. D., Wong, F. C. L., & Leeds, N. E. (1994). Reversible neurotoxicity of interleukin-2 and tumor necrosis factor: correlation of SPECT with neuropsychological testing. Journal of Neuropsychiatry and Clinical Neurosciences, 6, 285\u2013288.","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"key":"5_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/BF01050073","volume":"15","author":"C. A. Meyers","year":"1993","unstructured":"Meyers, C. A. & Yung, W. K. A. (1993). Delayed neurotoxicity of intraventricular interleukin-2: a case report. Journal of Neuro-Oncology, 15, 265\u2013267.","journal-title":"Journal of Neuro-Oncology"},{"key":"5_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/1097-0142(19910701)68:1<88::AID-CNCR2820680118>3.0.CO;2-5","volume":"68","author":"C. A. Meyers","year":"1991","unstructured":"Meyers, C. A., Obbens, E. A. M. T., Scheibel, R. S., & Moser, R. P. (1991). Neurotoxicity of intraventricularly administered alpha interferon for leptomeningeal disease. Cancer, 68, 88\u201391.","journal-title":"Cancer"},{"key":"5_CR15","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1212\/WNL.41.5.672","volume":"41","author":"C. A. Meyers","year":"1991","unstructured":"Meyers, C. A., Scheibel, R. S., & Forman, A. D. (1991). Persistent neurotoxicity of systemically administered interferon-alpha. Neurology, 41, 672\u2013676.","journal-title":"Neurology"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1212\/WNL.45.5.947","volume":"45","author":"M. A. Pavol","year":"1995","unstructured":"Pavol, M. A., Meyers, C. A., Rexer, J. L., Valentine, A. D., Mattis, P. J., & Talpaz, M. (1995). Pattern of neurobehavioral deficits associated with interferon-alfa therapy for leukemia. Neurology, 45, 947\u2013950.","journal-title":"Neurology"},{"issue":"Supplement 1","key":"5_CR17","first-page":"64","volume":"25","author":"C. R. Plata-Salaman","year":"1998","unstructured":"Plata-Salaman, C. R. (1998). Cytokines and anorexia: a brief overview. Seminars in Oncology, 25Supplement 1, 64\u201372.","journal-title":"Seminars in Oncology"},{"key":"5_CR18","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/BF00216072","volume":"96","author":"A. Smith","year":"1988","unstructured":"Smith, A., Tyrrell, D., Coyle, K., & Higgins, P. (1988). Effects of interferon alpha on performance in man: a preliminary study. Psychopharmacology, 96, 414\u2013416","journal-title":"Psychopharmacology"},{"key":"5_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1176\/jnp.9.2.273","volume":"9","author":"D. Strite","year":"1997","unstructured":"Strite, D., Valentine, A. D., & Meyers, C. A. (1997). Manic episodes in two patients treated with interferon alpha. Journal of Neuropsychiatry and Clinical Neurosciences, 9, 273\u2013276.","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"Supplement 1","key":"5_CR20","first-page":"23","volume":"25","author":"J. L. Taylor","year":"1998","unstructured":"Taylor, J. L. & Grossberg, S. E. (1998). The effects of interferon-\u03b1 on the production and action of other cytokines. Seminars in Oncology, 25Supplement 1, 23\u201329.","journal-title":"Seminars in Oncology"},{"key":"5_CR21","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3109\/07357909509024923","volume":"13","author":"A. D. Valentine","year":"1995","unstructured":"Valentine, A. D., Meyers, C. A., & Talpaz, M. (1995). Treatment of neurotoxic side effects of interferon-\u03b1 with naltrexone. Cancer Investigation, 13, 561\u2013566.","journal-title":"Cancer Investigation"},{"issue":"Supplement 1","key":"5_CR22","first-page":"39","volume":"25","author":"A. D. Valentine","year":"1998","unstructured":"Valentine, A. D., Meyers, C. A., Kling, M. A., Richelson, E., & Hauser, P. (1998). Mood and cognitive side effects of interferon-\u03b1 therapy. Seminars in Oncology, 25Supplement 1, 39\u201347.","journal-title":"Seminars in Oncology"}],"container-title":["Advances in Experimental Medicine and Biology","Cytokines, Stress, and Depression"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-0-585-37970-8_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T09:05:31Z","timestamp":1590051931000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-0-585-37970-8_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999]]},"ISBN":["9780306461354","9780585379708"],"references-count":22,"URL":"https:\/\/doi.org\/10.1007\/978-0-585-37970-8_5","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999]]},"assertion":[{"value":"23 November 2007","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}